Biotechnology Value Fund

Biotechnology Value Fund

Biotechnology Value Fund

Follow us
Alexa global traffic share
Latest investments Show all
$102,000,000
Venture capital (Series C)
Kymera Therapeutics
$90,000,000
Venture capital
Phathom Pharmaceuticals
Team Size
1–10
Employees
Past year's investments

Biotechnology Value Fund participated in fewer than 3 rounds over the past year

Latest rounds
  • Kymera Therapeutics: Venture capital (Series C) ($102M)
  • Phathom Pharmaceuticals: Venture capital ($90M)
  • Vividion Therapeutics: Venture capital (Series B) ($82M)